Stock HIGR HI-GREAT GROUP HOLDING COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hi-Great Group Holding Company

Equities

HIGR

US4283711087

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 03:40:02 2022-10-18 pm EDT 		5-day change 1st Jan Change
0.0178 USD -98.22% Intraday chart for Hi-Great Group Holding Company -.--% -.--%
2023 Hi-Great Group Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Hi-Great Group Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022
Capitalization 1 500 85 100 1.78
Enterprise Value (EV) 1 500 85.12 100 1.806
P/E ratio -23,697 x -6,693 x 1,623 x 539 x
Yield - - - -
Capitalization / Revenue - 441,611,205 x 378,509,731 x 8,563,703 x
EV / Revenue - 442,226,469 x 378,516,662 x 8,690,826 x
EV / EBITDA - - - -
EV / FCF - 6,373,047,619 x 1,461,160,593 x -22,069,651 x
FCF Yield - 0% 0% -0%
Price to Book -2,500,000 x -6,538 x 1,603 x 292 x
Nbr of stocks (in thousands) 100,000 100,000 100,000 100,000
Reference price 2 5.000 0.8500 1.000 0.0178
Announcement Date 2/24/22 2/24/22 7/12/22 4/17/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales - 0.1925 0.2642 0.2079
EBITDA - - - -
EBIT 1 -0.0208 -0.0113 0.062 0.003299
Operating Margin - -5.85% 23.46% 1.59%
Earnings before Tax (EBT) 1 -0.0179 -0.012 0.0617 0.0033
Net income 1 -0.0179 -0.0128 0.0617 0.0033
Net margin - -6.64% 23.34% 1.59%
EPS 2 -0.000211 -0.000127 0.000616 0.000033
Free Cash Flow - 0.0134 0.0684 -0.0819
FCF margin - 6.94% 25.91% -39.38%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - 110.99% -
Dividend per Share - - - -
Announcement Date 2/24/22 2/24/22 7/12/22 4/17/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 0 0.12 0 0.03
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - 0.01 0.07 -0.08
ROE (net income / shareholders' equity) - 193% 250% 59.9%
ROA (Net income/ Total Assets) - -6.86% 15.9% 0.87%
Assets 1 - 0.1863 0.3888 0.3781
Book Value Per Share 2 -0 -0 0 0
Cash Flow per Share 2 0 0 0 0
Capex - - - -
Capex / Sales - - - -
Announcement Date 2/24/22 2/24/22 7/12/22 4/17/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
HI-GREAT GROUP HOLDING COMPANY Stock Hi-Great Group Holding Company
-.--% 1.78M
MODERNA, INC. Stock Moderna, Inc.
+29.05% 49.18B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.18% 42.11B
LONZA GROUP AG Stock Lonza Group AG
+50.47% 40.37B
CELLTRION, INC. Stock Celltrion, Inc.
-5.26% 28.85B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.85% 26.09B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.06% 18.71B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+7.93% 13.26B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+32.35% 12.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-0.24% 11.99B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. HIGR Stock
  4. Financials Hi-Great Group Holding Company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW